AMPLYX PHARMACEUTICALS

amplyx-pharmaceuticals-logo

Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.

#SimilarOrganizations #People #Financial #Event #Website #More

AMPLYX PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Clinical Trials Medical Pharmaceutical

Founded:
2006-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.amplyx.com

Total Employee:
11+

Status:
Active

Contact:
+118583484458

Email Addresses:
[email protected]

Total Funding:
198.37 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Proofpoint Dyn DNS Dyn Hosting


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

arvinas-logo

Arvinas

Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.

zs-pharma-logo

ZS Pharma

ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.


Current Advisors List

ed-mathers_image

Ed Mathers Board Member @ Amplyx Pharmaceuticals
Board_member

mike-grey_image

Mike Grey Board Member @ Amplyx Pharmaceuticals
Board_member

niall-odonnell_image

Niall O'Donnell Board Member @ Amplyx Pharmaceuticals
Board_member

ed-mathers_image

Ed Mathers Board Member @ Amplyx Pharmaceuticals
Board_member

johan-kรถrdel_image

Johan Kรถrdel Board Member @ Amplyx Pharmaceuticals
Board_member
2017-08-01

anand-mehra_image

Anand Mehra Board Member @ Amplyx Pharmaceuticals
Board_member

paul-grint_image

Paul Grint Board Member @ Amplyx Pharmaceuticals
Board_member
2016-01-01

Current Employees Featured

mike-grey_image

Mike Grey
Mike Grey President & CEO @ Amplyx Pharmaceuticals
President & CEO
2015-10-01

chris-lemasters_image

Chris LeMasters
Chris LeMasters COO @ Amplyx Pharmaceuticals
COO

kevin-holme_image

Kevin Holme
Kevin Holme Senior Vice President of Development @ Amplyx Pharmaceuticals
Senior Vice President of Development

elaine-j-heron_image

Elaine J. Heron
Elaine J. Heron Director @ Amplyx Pharmaceuticals
Director
2009-02-01

paul-bien_image

Paul Bien
Paul Bien VP of Program Management & Operations @ Amplyx Pharmaceuticals
VP of Program Management & Operations

carlos-sattler_image

Carlos Sattler
Carlos Sattler SVP of Clinical Development @ Amplyx Pharmaceuticals
SVP of Clinical Development

pamela-wedel_image

Pamela Wedel
Pamela Wedel VP of Clinical Operations @ Amplyx Pharmaceuticals
VP of Clinical Operations

Founder


andre-marquis_image

Andre Marquis

gerald-crabtree_image

Gerald Crabtree

mitchell-mutz_image

Mitchell Mutz

Investors List

pappas-capital_image

Pappas Capital

Pappas Capital investment in Series C - Amplyx Pharmaceuticals

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series C - Amplyx Pharmaceuticals

arix-bioscience_image

Arix Bioscience

Arix Bioscience investment in Series C - Amplyx Pharmaceuticals

pfizer_image

Pfizer

Pfizer investment in Series C - Amplyx Pharmaceuticals

biomed-ventures_image

BioMed Ventures

BioMed Ventures investment in Series C - Amplyx Pharmaceuticals

rivervest_image

RiverVest

RiverVest investment in Series C - Amplyx Pharmaceuticals

lundbeckfond-ventures_image

Lundbeckfonden Ventures

Lundbeckfonden Ventures investment in Series C - Amplyx Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series C - Amplyx Pharmaceuticals

3x5-partners_image

3ร—5 Partners

3ร—5 Partners investment in Series C - Amplyx Pharmaceuticals

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series C - Amplyx Pharmaceuticals

Official Site Inspections

http://www.amplyx.com

  • Host name: 147.154.27.36
  • IP address: 147.154.27.36
  • Location: Seattle United States
  • Latitude: 47.6109
  • Longitude: -122.3303
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98101

Loading ...

More informations about "Amplyx Pharmaceuticals" on Search Engine